These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23315994)

  • 1. Beneficial effects of (pGlu-Gln)-CCK-8 on energy intake and metabolism in high fat fed mice are associated with alterations of hypothalamic gene expression.
    Montgomery IA; Irwin N; Flatt PR
    Horm Metab Res; 2013 Jun; 45(6):471-3. PubMed ID: 23315994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical cholecystokinin receptor activation protects against obesity-diabetes in high fat fed mice and has sustainable beneficial effects in genetic ob/ob mice.
    Irwin N; Montgomery IA; Moffett RC; Flatt PR
    Biochem Pharmacol; 2013 Jan; 85(1):81-91. PubMed ID: 23085436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic effects of activation of CCK receptor signaling pathways by twice-daily administration of the enzyme-resistant CCK-8 analog, (pGlu-Gln)-CCK-8, in normal mice.
    Irwin N; Frizelle P; O'Harte FP; Flatt PR
    J Endocrinol; 2013 Jan; 216(1):53-9. PubMed ID: 23055535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of independent and combined metabolic effects of chronic treatment with (pGlu-Gln)-CCK-8 and long-acting GLP-1 and GIP mimetics in high fat-fed mice.
    Irwin N; Hunter K; Montgomery IA; Flatt PR
    Diabetes Obes Metab; 2013 Jul; 15(7):650-9. PubMed ID: 23388064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel CCK-8/GLP-1 Hybrid Peptide Exhibiting Prominent Insulinotropic, Glucose-Lowering, and Satiety Actions With Significant Therapeutic Potential in High-Fat-Fed Mice.
    Irwin N; Pathak V; Flatt PR
    Diabetes; 2015 Aug; 64(8):2996-3009. PubMed ID: 25883113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the independent and combined metabolic effects of subchronic modulation of CCK and GIP receptor action in obesity-related diabetes.
    Irwin N; Montgomery IA; O'Harte FP; Frizelle P; Flatt PR
    Int J Obes (Lond); 2013 Aug; 37(8):1058-63. PubMed ID: 23164696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the metabolic effects of sustained CCK1 receptor activation alone and in combination with upregulated leptin signalling in high-fat-fed mice.
    Irwin N; Montgomery IA; Flatt PR
    Diabetologia; 2013 Jun; 56(6):1425-35. PubMed ID: 23462797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (pGlu-Gln)-CCK-8[mPEG]: a novel, long-acting, mini-PEGylated cholecystokinin (CCK) agonist that improves metabolic status in dietary-induced diabetes.
    Irwin N; Frizelle P; O'Harte FP; Flatt PR
    Biochim Biophys Acta; 2013 Aug; 1830(8):4009-16. PubMed ID: 23583730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of feed restriction and supplemental dietary fat on gut peptide and hypothalamic neuropeptide messenger ribonucleic acid concentrations in growing wethers.
    Relling AE; Pate JL; Reynolds CK; Loerch SC
    J Anim Sci; 2010 Feb; 88(2):737-48. PubMed ID: 19897637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effects of the novel cholecystokinin agonist (pGlu-Gln)-CCK-8 in mouse models of obesity/diabetes.
    Irwin N; Frizelle P; Montgomery IA; Moffett RC; O'Harte FPM; Flatt PR
    Diabetologia; 2012 Oct; 55(10):2747-2758. PubMed ID: 22814764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Voglibose administration regulates body weight and energy intake in high fat-induced obese mice.
    Do HJ; Jin T; Chung JH; Hwang JW; Shin MJ
    Biochem Biophys Res Commun; 2014 Jan; 443(3):1110-7. PubMed ID: 24388987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial long-term antidiabetic actions of N- and C-terminally modified analogues of apelin-13 in diet-induced obese diabetic mice.
    Parthsarathy V; Hogg C; Flatt PR; O'Harte FPM
    Diabetes Obes Metab; 2018 Feb; 20(2):319-327. PubMed ID: 28730728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Various dietary fats differentially change the gene expression of neuropeptides involved in body weight regulation in rats.
    Dziedzic B; Szemraj J; Bartkowiak J; Walczewska A
    J Neuroendocrinol; 2007 May; 19(5):364-73. PubMed ID: 17425611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic regulation of hypothalamic neuropeptide gene expression and food intake by melanocortin analogues and reversal with melanocortin-4 receptor antagonist.
    Kim RY; Shin SW; Kim BJ; Lee W; Baik JH
    Biochem Biophys Res Commun; 2005 Apr; 329(4):1178-85. PubMed ID: 15766551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of hypothalamic NPY, AgRP, MC4R, AND IL-6 mRNA levels in young Lewis rats with early-life diet-induced obesity.
    Stofkova A; Skurlova M; Kiss A; Zelezna B; Zorad S; Jurcovicova J
    Endocr Regul; 2009 Jul; 43(3):99-106. PubMed ID: 19817504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whey protein isolate counteracts the effects of a high-fat diet on energy intake and hypothalamic and adipose tissue expression of energy balance-related genes.
    McAllan L; Keane D; Schellekens H; Roche HM; Korpela R; Cryan JF; Nilaweera KN
    Br J Nutr; 2013 Dec; 110(11):2114-26. PubMed ID: 23731955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic metabolic benefits of an exenatide analogue and cholecystokinin in diet-induced obese and leptin-deficient rodents.
    Trevaskis JL; Sun C; Athanacio J; D'Souza L; Samant M; Tatarkiewicz K; Griffin PS; Wittmer C; Wang Y; Teng CH; Forood B; Parkes DG; Roth JD
    Diabetes Obes Metab; 2015 Jan; 17(1):61-73. PubMed ID: 25204356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leptin infusion and obesity in mouse cause alterations in the hypothalamic melanocortin system.
    Gout J; Sarafian D; Tirard J; Blondet A; Vigier M; Rajas F; Mithieux G; Begeot M; Naville D
    Obesity (Silver Spring); 2008 Aug; 16(8):1763-9. PubMed ID: 18551122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-dependent hypothalamic expression of neuropeptides in wild-type and melanocortin-4 receptor-deficient mice.
    Arens J; Moar KM; Eiden S; Weide K; Schmidt I; Mercer JG; Simon E; Korf HW
    Physiol Genomics; 2003 Dec; 16(1):38-46. PubMed ID: 14559977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential responses of orexigenic neuropeptides to fasting in offspring of obese mothers.
    Chen H; Morris MJ
    Obesity (Silver Spring); 2009 Jul; 17(7):1356-62. PubMed ID: 19282828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.